BioSpace News Archive

Alpha Pro Tech, Ltd. (NYSE American: APT), a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building products, today announced financial results for the fourth quarter and year ended December 31, 2019.

Feb. 26, 2020 12:00 UTC CAMBRIDGE, Mass.--( BUSINESS WIRE )-- Gemini Therapeutics, a clinical stage precision medicine company developing innovative treatments for dry Age-related Macular Degeneration (AMD) and linked ocular disorders, today announced a collaboration with the Singapore Eye Research Institute (SERI) to expand knowledge and identify new targets associated with AMD. Under the terms of the agreement, SERI and Gemini will explore the link between genetic and poten

Feb. 26, 2020 12:00 UTC Triplet Therapeutics to Present at Cowen 40 th Annual Health Care Conference CAMBRIDGE, Mass.--( BUSINESS WIRE )-- Triplet Therapeutics, Inc. , a biotechnology company harnessing new insights from human genetics to develop transformative treatments for repeat expansion disorders, today announced that Nessan Bermingham, Ph.D., Triplet’s co-founder, president and chief executive officer, will present at the Cowen and Company 40 th Annual Health Care Confere

Feb. 26, 2020 12:00 UTC CAMBRIDGE, Mass.--( BUSINESS WIRE )-- Acceleron Pharma Inc. (Nasdaq:XLRN), a leading biopharmaceutical company in the discovery and development of TGF-beta superfamily therapeutics intended to treat serious and rare diseases, today announced that senior management will participate in two upcoming healthcare investor conferences. Conference Presentation Details: Event: Cowen & Co. 40th Annual Health Care Conference Date/Time: Monday, Ma

MIT Technology Review’s “10 Breakthrough Technologies List of 2020” named Kebotix, a technology platform company for new chemicals and materials, as a key player in the field of AI-designed molecules.

-- First inhaled mRNA therapeutic remains on track to report results from its ongoing multiple-ascending dose (MAD) portion of Phase 1/2 clinical trial in the third quarter of 2020 -- LEXINGTON, Mass., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Translate Bio, Inc. (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction, today announced that the U.S. Food and Drug A

CUPERTINO, Calif. , Feb. 26, 2020 /PRNewswire / -- DURECT Corporation (Nasdaq: DRRX) today announced that it will report its fourth quarter and year ended December 31, 2019 financial results and host a conference call after the market close on Tuesday, March 3, 2020 . Tuesday March 3 rd @ 4:30pmET/1:30 p.m. Pacific Time Toll Free: 877-407-0

RIOMET ER™ (metformin hydrochloride for extended-release oral suspension) is the first and only U.S. FDA-approved extended-release liquid formulation of metformin

Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company is pleased to announce that it will be featured on an upcomingBioPub webcast hosted by Dr. KSS on Friday February 28th, 2020 at noon EST.

Exact Sciences Corp. announced that company management will participate in the following investor conferences and invited investors to participate by webcast.